We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.8B Turnover 33.11%
1-Year Est. Return 26.98%
 

Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.

This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+26.98%
3 Year Est. Return
+88.41%
5 Year Est. Return
+62.11%
10 Year Est. Return
+188.73%
AUM
$7.55B
AUM Growth
+$1.25B
Cap. Flow
+$1.17B
Cap. Flow %
15.56%
Top 10 Hldgs %
9.43%
Holding
2,269
New
635
Increased
628
Reduced
448
Closed
556
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17%
2 Financials 13.53%
3 Healthcare 13.33%
4 Technology 13.18%
5 Industrials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
META icon
851
Meta Platforms (Facebook)
META
$1.52T
$1.13M 0.01%
5,800
-211,982
-97% -$38.3M
2016 Q2
8 quarters
TPH icon
852
DELISTED
Tri Pointe Homes
TPH
$1.13M 0.01%
68,888
-40,138
-37% -$683K
2017 Q3
3 quarters
FBP icon
853
First Bancorp
FBP
$3.62B
$1.12M 0.01%
145,825
+77,800
+114% +$576K
2016 Q4
6 quarters
MORN icon
854
Morningstar
MORN
$8.64B
$1.11M 0.01%
+8,650
New +$989K
2018 Q2
0 quarters
TVTX icon
855
Travere Therapeutics
TVTX
$4.64B
$1.11M 0.01%
40,641
+28,941
+247% +$771K
2018 Q1
1 quarter
CCXI icon
856
DELISTED
ChemoCentryx
CCXI
$1.11M 0.01%
+84,154
New +$1.01M
2018 Q2
0 quarters
DCPH icon
857
DELISTED
Deciphera Pharmaceuticals
DCPH
$1.1M 0.01%
+28,057
New +$826K
2018 Q2
0 quarters
MNRO icon
858
Monro
MNRO
$306M
$1.1M 0.01%
18,957
+11,230
+145% +$634K
2017 Q4
2 quarters
ASML icon
859
ASML
ASML
$523B
$1.1M 0.01%
5,533
-7,571
-58% -$1.52M
2017 Q3
3 quarters
TGNA icon
860
DELISTED
TEGNA Inc
TGNA
$1.09M 0.01%
100,822
-143,884
-59% -$1.56M
2017 Q1
5 quarters
CBPO
861
DELISTED
China Biologic Products Holdings
CBPO
$1.09M 0.01%
+11,017
New +$952K
2018 Q2
0 quarters
MTOR
862
DELISTED
Meritor
MTOR
$1.09M 0.01%
53,107
+25,107
+90% +$527K
2017 Q4
2 quarters
HOME
863
DELISTED
At Home Group
HOME
$1.09M 0.01%
27,800
+13,960
+101% +$501K
2017 Q4
2 quarters
ATO icon
864
Atmos Energy
ATO
$28.7B
$1.08M 0.01%
12,018
+9,191
+325% +$796K
2018 Q1
1 quarter
KFRC icon
865
Kforce
KFRC
$958M
$1.08M 0.01%
31,510
+14,394
+84% +$454K
2017 Q3
3 quarters
LXFT
866
DELISTED
Luxoft Holding
LXFT
$1.08M 0.01%
+29,299
New +$1.13M
2018 Q2
0 quarters
WOR icon
867
Worthington Enterprises
WOR
$2.79B
$1.08M 0.01%
41,546
+19,185
+86% +$543K
2018 Q1
1 quarter
KEX icon
868
Kirby
KEX
$6.52B
$1.07M 0.01%
12,845
-21,835
-63% -$1.89M
2018 Q1
1 quarter
HZNP
869
DELISTED
Horizon Therapeutics
HZNP
$1.07M 0.01%
64,700
+36,700
+131% +$560K
2017 Q3
3 quarters
CATO icon
870
Cato
CATO
$37.4M
$1.07M 0.01%
+43,336
New +$854K
2018 Q2
0 quarters
NPO icon
871
Enpro
NPO
$5.59B
$1.06M 0.01%
15,166
+9,979
+192% +$745K
2017 Q4
2 quarters
AAOI icon
872
Applied Optoelectronics
AAOI
$3.58B
$1.06M 0.01%
+23,610
New +$839K
2018 Q2
0 quarters
CHGG icon
873
Chegg
CHGG
$56.6M
$1.05M 0.01%
+37,700
New +$948K
2018 Q2
0 quarters
LDOS icon
874
Leidos
LDOS
$15.2B
$1.04M 0.01%
17,718
-33,292
-65% -$2.08M
2017 Q3
3 quarters
AVP
875
DELISTED
Avon Products
AVP
$1.04M 0.01%
643,963
+618,063
+2,386% +$1.31M
2017 Q2
4 quarters

Similar funds

Squarepoint's Q2 2018 Portfolio in Review

As of Q2 2018, Squarepoint held 2,269 positions worth $7.55B, up 20% from $6.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Squarepoint deployed $1.17B of net new capital in Q2 2018, opening 635 new positions and adding to 628 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI India ETF, an estimated $47.3M trimmed.

  • Squarepoint's largest Q2 2018 buy was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.
  • Squarepoint added most to iShares MSCI Taiwan ETF in Q2 2018, an estimated $102M increase.
  • Squarepoint's biggest Q2 2018 reduction was iShares MSCI India ETF, cutting an estimated $47.3M.
  • Squarepoint fully exited iShares MSCI Brazil ETF in Q2 2018, selling an estimated $119M.
  • Squarepoint's ten largest holdings make up 9.4% of its $7.55B portfolio in Q2 2018.
  • Squarepoint opened 635 new positions and closed 556 in Q2 2018.
  • Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.55B.

Based on Squarepoint's 13F filing for Q2 2018, filed 14 Aug 2018.